TRINITY BIOTECH PUBLIC LIMITED COMPANY

Trinity Biotech plc is a publicly-listed specialist in the development, manufacture and marketing of clinical diagnostic products. The company focuses on delivering high-performance solutions that enable laboratories and point-of-care settings to detect and monitor a wide range of health conditions quickly and accurately.

Its portfolio includes the Premier Resolution HPLC analyser for thalassaemia and haemoglobin variant detection, the Bartels® FlexTrans™ Transport Medium designed to suppress microbial contamination during specimen transport, and a single-use immunoassay for rapid detection of HIV-1 and HIV-2 antibodies in serum, plasma or whole blood. Recent regulatory milestones have expanded its offering to include the FDA-cleared PreClara™ pre-eclampsia testing service and a breakthrough continuous glucose-monitoring sensor, while off-shoring of its flagship rapid HIV test has bolstered strategic and financial performance. Trinity Biotech's innovations serve healthcare providers worldwide, helping them achieve faster, more reliable diagnostic outcomes.